<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: Biotechnology Industry News</title><link>http://biz.yahoo.com/ic/news/515.html</link><description>The latest news on the Biotechnology industry from Yahoo! Finance</description><language>en-US</language><lastBuildDate>Mon, 28 May 2012 14:25:56 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title></title><link></link><width>144</width><height>45</height></image><item><title>3 Health-Care Stocks Crushing the Market</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1341pfh6k/*http://www.fool.com/investing/high-growth/2012/05/26/3-health-care-stocks-crushing-the-market.aspx?ticker=VRTX&amp;source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3584889826</guid><pubDate>Mon, 28 May 2012 14:25:56 GMT</pubDate></item><item><title>5 Cash Hoarding Small Cap Healthcare Stocks With Analyst Love</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=136bev3si/*http://seekingalpha.com/article/621121-5-cash-hoarding-small-cap-healthcare-stocks-with-analyst-love?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2973409825</guid><pubDate>Mon, 28 May 2012 13:58:20 GMT</pubDate></item><item><title>These Biotechs May Break Out While Vivus And Arena Battle It Out</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=1392ml41d/*http://seekingalpha.com/article/620871-these-biotechs-may-break-out-while-vivus-and-arena-battle-it-out?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/26162067</guid><pubDate>Mon, 28 May 2012 12:28:38 GMT</pubDate></item><item><title>Genetic Technologies and Complete Genomics Strong Performers in a Booming Industry</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/genetic-technologies-complete-genomics-strong-122000445.html</link><description>[Marketwire] - NEW YORK, NY-- - The Biotechnology Industry has shown investors some impressive gains this year. The SPDR S&amp;P Biotech ETF is up nearly 25 percent year-to-date. As large pharmaceuticals face major patent ...</description><guid isPermaLink="false">yahoo_finance/3866353727</guid><pubDate>Mon, 28 May 2012 12:25:07 GMT</pubDate></item><item><title>[video] NPS Pharma CEO: Market Recognizing Pipeline Potential</title><link>http://us.rd.yahoo.com/finance/external/video/tsmfe/rss/SIG=13cih1amu/*http://www.thestreet.com/_yahoo/story/11554462/1/nps-pharma-ceo-market-recognizing-pipeline-potential.html?cm_ven=YAHOOV&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/148575149</guid><pubDate>Mon, 28 May 2012 10:30:00 GMT</pubDate></item><item><title>Hope Springs Eternal In Biotech</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=1285q3bai/*http://seekingalpha.com/article/620561-hope-springs-eternal-in-biotech?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2607138934</guid><pubDate>Mon, 28 May 2012 09:04:54 GMT</pubDate></item><item><title>Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 5</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=130s3bocg/*http://seekingalpha.com/article/620351-biotechnology-stocks-to-watch-ahead-of-asco-2012-part-5?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2177841021</guid><pubDate>Mon, 28 May 2012 06:50:26 GMT</pubDate></item><item><title>Best Performing Stocks In 2012</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=127uk4suu/*http://seekingalpha.com/article/620051-best-performing-stocks-in-2012?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/350142297</guid><pubDate>Mon, 28 May 2012 04:28:48 GMT</pubDate></item><item><title>The Meaningless Drug Approval That Could Cost the Industry Billions</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=139b2idle/*http://www.fool.com/investing/general/2012/05/25/the-meaningless-drug-approval-that-could-cost-the.aspx?ticker=SGEN&amp;source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2527870111</guid><pubDate>Sun, 27 May 2012 20:38:18 GMT</pubDate></item><item><title>The Meaningless Drug Approval That Could Cost the Industry Billions</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=139b2idle/*http://www.fool.com/investing/general/2012/05/25/the-meaningless-drug-approval-that-could-cost-the.aspx?ticker=GILD&amp;source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/106056584</guid><pubDate>Sun, 27 May 2012 20:38:17 GMT</pubDate></item><item><title>3 Reasons To Buy Onyx Pharmaceuticals</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12els5p98/*http://seekingalpha.com/article/619881-3-reasons-to-buy-onyx-pharmaceuticals?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/3057146784</guid><pubDate>Sun, 27 May 2012 17:41:18 GMT</pubDate></item><item><title>3SBio Inc. To Present at the DB Access Asia Conference 2012</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/3sbio-inc-present-db-access-150100218.html</link><description>[PR Newswire] - SHENYANG, China, May 27, 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX) (&quot;3SBio&quot; or &quot;the Company&quot;), a leading China-based biotechnology company focused on researching, developing, ...</description><guid isPermaLink="false">yahoo_finance/2045184810</guid><pubDate>Sun, 27 May 2012 15:01:00 GMT</pubDate></item><item><title>Is This Biotech&apos;s Best Stock?</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12jl9vvgk/*http://www.fool.com/investing/general/2012/05/27/is-this-biotechs-best-stock.aspx?ticker=IDIX&amp;source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/93615273</guid><pubDate>Sun, 27 May 2012 13:12:49 GMT</pubDate></item><item><title>Arena is Hands Down a Better Investment than Vivus</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12hnujnde/*http://beta.fool.com/beatlesforever/2012/05/27/why-arena-better-buy-vivis/5026/?source=eogyholnk0000001</link><description></description><guid isPermaLink="false">yahoo_finance/1693899061</guid><pubDate>Sun, 27 May 2012 12:20:00 GMT</pubDate></item><item><title>Shorter Timeframe, More Risky</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12oh6h8ac/*http://www.fool.com/investing/high-growth/2012/05/24/shorter-timeframe-more-risky.aspx?ticker=MNKD&amp;source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/18920494</guid><pubDate>Sat, 26 May 2012 19:12:17 GMT</pubDate></item><item><title>4 Crucial Ingredients for the Perfect Investor</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13651jlqg/*http://www.fool.com/investing/general/2012/05/24/4-crucial-ingredients-for-the-perfect-investor.aspx?ticker=ILMN&amp;source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/1269797079</guid><pubDate>Sat, 26 May 2012 17:51:58 GMT</pubDate></item><item><title>3 Health-Care Stocks Crushing the Market</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1341pfh6k/*http://www.fool.com/investing/high-growth/2012/05/26/3-health-care-stocks-crushing-the-market.aspx?ticker=ARNA&amp;source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/84922876</guid><pubDate>Sat, 26 May 2012 14:26:01 GMT</pubDate></item><item><title>The Rosen Law Firm Reminds Chelsea Therapeutics International, Ltd. Investors of Important Class Action Deadline -- CHTP</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/rosen-law-firm-reminds-chelsea-131412638.html</link><description>[GlobeNewswire] - NEW YORK -- The Rosen Law Firm, P.A. reminds investors of the important June 4, 2012 lead plaintiff deadline in the securities class action on behalf of purchasers of Chelsea Therapeutics International, ...</description><guid isPermaLink="false">yahoo_finance/3251192932</guid><pubDate>Sat, 26 May 2012 13:14:12 GMT</pubDate></item><item><title>ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule Inhibitor of C5aR, at the 49th European Renal Association - European Dialysis and Transplant Association Congress</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/chemocentryx-presents-data-ccx168-orally-073000094.html</link><description>[GlobeNewswire] - MOUNTAIN VIEW, Calif. -- ChemoCentryx, Inc. , today announced the presentation of results from the Company&apos;s development program for CCX168, an investigational orally administered inhibitor of the complement ...</description><guid isPermaLink="false">yahoo_finance/3895290179</guid><pubDate>Sat, 26 May 2012 09:58:50 GMT</pubDate></item><item><title>Dendreon Announces Webcast Presentations at Upcoming Conferences</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/dendreon-announces-webcast-presentations-upcoming-003400393.html</link><description>[Business Wire] - May 25, 2012--Dendreon Corporation today announced that management will present at the following conferences:</description><guid isPermaLink="false">yahoo_finance/1280075334</guid><pubDate>Sat, 26 May 2012 00:34:00 GMT</pubDate></item><item><title>Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=1301dfmp9/*http://seekingalpha.com/article/619261-biotechnology-stocks-to-watch-ahead-of-asco-2012-part-3?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/3302813331</guid><pubDate>Sat, 26 May 2012 00:25:08 GMT</pubDate></item><item><title>Final Glance: Biotechnology companies</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/final-glance-biotechnology-companies-220355649.html</link><description></description><guid isPermaLink="false">yahoo_finance/670566981</guid><pubDate>Fri, 25 May 2012 22:08:56 GMT</pubDate></item></channel></rss><!-- c1.finance.sp2.yahoo.com compressed/chunked Tue May 29 01:47:50 UTC 2012 -->

